can you take semaglutide if you have breast cancer A brand new study just presented at ASCO 2026 found that women on GLP-1 medications had ~30% lower incidence compared to women not on them — controlling for age, race, BMI, breast Early research suggests that people

There should be much more transparency in the regulatory process about how they deal with the concerns that are raised, Clark said

If you do discontinue therapy, staying connected with your provider and monitoring your weight trends allows early intervention if regain begins

Obesity itself promotes chronic low-grade inflammation through adipose tissue secretion of inflammatory cytokines

Armed with genetic data, PlexusDx clinicians tailor your GLP-1 protocol to match your individual biology rather than applying a one-size-fits-all approach

Low-potency steroids: Dermatologist-prescribed, low-potency, topical steroids (like hydrocortisone) can help with inflammation, which in turn can fade the patches of dark pigment